David Sanders

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]

Welcome to our MedTech Services Report. This sets out our views on the tailwinds driving growth and increased outsourcing, an overview of the MedTech CDMO and CRO market as well as the key drivers of consolidation in the sector. We hope that you enjoy this report and look forward to discussing the data and underlying […]

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector.  As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]

We are very excited to share that we have agreed to join forces with Canaccord Genuity – a leading full-service investment bank serving growth companies in the middle market.  This is an important milestone in our journey and we wanted to update you on why we’ve taken this decision and what it means for you. […]

We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector.  For some time, CG Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, […]

The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’. […]

As a sector for external investment, the UK Care Services market hardly has novelty value – the sector has been shaped for decades by successive waves of capital from private and institutional investors. Equally, while success stories proliferate, there have been several high profile failures, of which the Four Seasons saga is only the most […]

Children’s Services has been one of the more resilient areas within UK care over the last 2 years, and also one of the most active for M&A. Our recent webinar looked at how businesses in the sector have faced the challenges posed by the COVID-19 outbreak, how conditions might look as the lock-down eases, and […]

Children’s Services has been one of the more resilient areas within UK care over the last 2 years, and also one of the most active for M&A. This webinar looks at how businesses in the sector have faced the challenges posed by the COVID-19 outbreak, how conditions might look as the lock-down eases, and the […]